News
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...
This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...
Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...
Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...
Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...
Driving Restrictions Beyond 1 Month After CAR-T Therapy Not Needed for All Patients, Researchers Say
Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.
Explore a high-throughput picodroplet-based method for CAR-T cell functional validation that enables rapid, single-cell ...
Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...
US researchers have engineered a new ‘smart’ immune cell that when activated by ultrasound can continuously sense and destroy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results